These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37775315)

  • 1. Pattern of Brain Parenchymal Damage Related to Cerebral Small Vessel Disease in Carriers of Rare
    Liu ZY; Zhai FF; Liu JY; Zhou YJ; Shu MJ; Huang XH; Han F; Li ML; Zhou LX; Ni J; Yao M; Zhang SY; Cui LY; Jin ZY; Zhu YC
    Neurology; 2023 Nov; 101(20):e1979-e1991. PubMed ID: 37775315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare
    Liu JY; Yao M; Dai Y; Han F; Zhai FF; Zhang DD; Zhou LX; Ni J; Zhang SY; Cui LY; Zhu YC
    Stroke; 2021 Dec; 52(12):3918-3925. PubMed ID: 34404235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of variants in HTRA1 and NOTCH3 with MRI-defined extremes of cerebral small vessel disease in older subjects.
    Mishra A; Chauhan G; Violleau MH; Vojinovic D; Jian X; Bis JC; Li S; Saba Y; Grenier-Boley B; Yang Q; Bartz TM; Hofer E; Soumaré A; Peng F; Duperron MG; Foglio M; Mosley TH; Schmidt R; Psaty BM; Launer LJ; Boerwinkle E; Zhu Y; Mazoyer B; Lathrop M; Bellenguez C; Van Duijn CM; Ikram MA; Schmidt H; Longstreth WT; Fornage M; Seshadri S; Joutel A; Tzourio C; Debette S
    Brain; 2019 Apr; 142(4):1009-1023. PubMed ID: 30859180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants of the NOTCH3 gene in the elderly and magnetic resonance imaging correlates of age-related cerebral small vessel disease.
    Schmidt H; Zeginigg M; Wiltgen M; Freudenberger P; Petrovic K; Cavalieri M; Gider P; Enzinger C; Fornage M; Debette S; Rotter JI; Ikram MA; Launer LJ; Schmidt R;
    Brain; 2011 Nov; 134(Pt 11):3384-97. PubMed ID: 22006983
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Cho BPH; Nannoni S; Harshfield EL; Tozer D; Gräf S; Bell S; Markus HS
    J Neurol Neurosurg Psychiatry; 2021 Jul; 92(7):694-701. PubMed ID: 33712516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteine-Altering
    Hack RJ; Rutten JW; Person TN; Li J; Khan A; Griessenauer CJ; ; Abedi V; Lesnik Oberstein SAJ; Zand R
    Stroke; 2020 Dec; 51(12):3562-3569. PubMed ID: 33161844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal patterns of leukoaraiosis and brain atrophy in symptomatic small vessel disease.
    Lambert C; Benjamin P; Zeestraten E; Lawrence AJ; Barrick TR; Markus HS
    Brain; 2016 Apr; 139(Pt 4):1136-51. PubMed ID: 26936939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad phenotype of cysteine-altering
    Rutten JW; Hack RJ; Duering M; Gravesteijn G; Dauwerse JG; Overzier M; van den Akker EB; Slagboom E; Holstege H; Nho K; Saykin A; Dichgans M; Malik R; Lesnik Oberstein SAJ
    Neurology; 2020 Sep; 95(13):e1835-e1843. PubMed ID: 32732295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's Disease, NOTCH3 Genetic Variants, and White Matter Hyperintensities.
    Ramirez J; Dilliott AA; Binns MA; Breen DP; Evans EC; Beaton D; McLaughlin PM; Kwan D; Holmes MF; Ozzoude M; Scott CJM; Strother SC; Symons S; Swartz RH; Grimes D; Jog M; Masellis M; Black SE; Joutel A; Marras C; Rogaeva E; Hegele RA; Lang AE;
    Mov Disord; 2020 Nov; 35(11):2090-2095. PubMed ID: 32573853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of
    Hack RJ; Cerfontaine MN; Gravesteijn G; Tap S; Hafkemeijer A; van der Grond J; Witjes-Ané MN; Baas F; Rutten JW; Lesnik Oberstein SAJ
    Stroke; 2022 Oct; 53(10):3133-3144. PubMed ID: 35862191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural Substrates of Psychomotor Speed Deficits in Cerebral Small Vessel Disease: A Brain Disconnectome Mapping Study.
    da Silva PHR; de Leeuw FE; Zotin MCZ; Neto OMP; Leoni RF; Tuladhar AM
    Brain Topogr; 2023 Jul; 36(4):545-553. PubMed ID: 37156893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired functional network properties contribute to white matter hyperintensity related cognitive decline in patients with cerebral small vessel disease.
    Wang Y; Liu X; Hu Y; Yu Z; Wu T; Wang J; Liu J; Liu J
    BMC Med Imaging; 2022 Mar; 22(1):40. PubMed ID: 35264145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV infection and cerebral small vessel disease are independently associated with brain atrophy and cognitive impairment.
    Sanford R; Strain J; Dadar M; Maranzano J; Bonnet A; Mayo NE; Scott SC; Fellows LK; Ances BM; Collins DL
    AIDS; 2019 Jun; 33(7):1197-1205. PubMed ID: 30870193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial Relation Between White Matter Hyperintensities and Incident Lacunes of Presumed Vascular Origin: A 14-Year Follow-Up Study.
    Yi F; Cai M; Jacob MA; Marques J; Norris DG; Duering M; Tuladhar AM; de Leeuw FE
    Stroke; 2022 Dec; 53(12):3688-3695. PubMed ID: 36189679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Regional White Matter Hyperintensities With Longitudinal Alzheimer-Like Pattern of Neurodegeneration in Older Adults.
    Rizvi B; Lao PJ; Chesebro AG; Dworkin JD; Amarante E; Beato JM; Gutierrez J; Zahodne LB; Schupf N; Manly JJ; Mayeux R; Brickman AM
    JAMA Netw Open; 2021 Oct; 4(10):e2125166. PubMed ID: 34609497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Vascular Risk Factors and Genetic Factors With Penetrance of Variants Causing Monogenic Stroke.
    Cho BPH; Harshfield EL; Al-Thani M; Tozer DJ; Bell S; Markus HS
    JAMA Neurol; 2022 Dec; 79(12):1303-1311. PubMed ID: 36300346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous investigation of microvasculature and parenchyma in cerebral small vessel disease using intravoxel incoherent motion imaging.
    Wong SM; Zhang CE; van Bussel FC; Staals J; Jeukens CR; Hofman PA; van Oostenbrugge RJ; Backes WH; Jansen JF
    Neuroimage Clin; 2017; 14():216-221. PubMed ID: 28180080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-exome sequencing reveals a role of HTRA1 and EGFL8 in brain white matter hyperintensities.
    Malik R; Beaufort N; Frerich S; Gesierich B; Georgakis MK; Rannikmäe K; Ferguson AC; Haffner C; Traylor M; Ehrmann M; Sudlow CLM; Dichgans M
    Brain; 2021 Oct; 144(9):2670-2682. PubMed ID: 34626176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia.
    Vipin A; Kumar D; Soo SA; Zailan FZ; Leow YJ; Koh CL; Ng ASL; Ng KP; Kandiah N
    Alzheimers Res Ther; 2023 Jun; 15(1):103. PubMed ID: 37270543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain atrophy and strategic lesion location increases risk of parkinsonism in cerebral small vessel disease.
    Bergkamp MI; Tuladhar AM; van der Holst HM; van Leijsen EMC; Ghafoorian M; van Uden IWM; van Dijk EJ; Norris DG; Platel B; Esselink RAJ; Leeuw FE
    Parkinsonism Relat Disord; 2019 Apr; 61():94-100. PubMed ID: 30448096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.